1. Shared and distinct pathways and networks genetically linked to coronary artery disease between human and mouse
- Author
-
Kurt, Zeyneb, Cheng, Jenny, Barrere-Cain, Rio, McQuillen, Caden N, Saleem, Zara, Hsu, Neil, Jiang, Nuoya, Pan, Calvin, Franzén, Oscar, Koplev, Simon, Wang, Susanna, Björkegren, Johan, Lusis, Aldons J, Blencowe, Montgomery, and Yang, Xia
- Subjects
Biological Sciences ,Genetics ,Cardiovascular ,Heart Disease ,Heart Disease - Coronary Heart Disease ,Aging ,Atherosclerosis ,Biotechnology ,Human Genome ,2.1 Biological and endogenous factors ,Humans ,Mice ,Animals ,Coronary Artery Disease ,Gene Regulatory Networks ,Genome-Wide Association Study ,Polymorphism ,Single Nucleotide ,Genetic Predisposition to Disease ,atherosclerosis ,coronary artery disease ,gene regulatory networks ,multiomics ,cross-species comparison ,Human ,Mouse ,computational biology ,human ,mouse ,systems biology ,Biochemistry and Cell Biology ,Biological sciences ,Biomedical and clinical sciences ,Health sciences - Abstract
Mouse models have been used extensively to study human coronary artery disease (CAD) or atherosclerosis and to test therapeutic targets. However, whether mouse and human share similar genetic factors and pathogenic mechanisms of atherosclerosis has not been thoroughly investigated in a data-driven manner. We conducted a cross-species comparison study to better understand atherosclerosis pathogenesis between species by leveraging multiomics data. Specifically, we compared genetically driven and thus CAD-causal gene networks and pathways, by using human GWAS of CAD from the CARDIoGRAMplusC4D consortium and mouse GWAS of atherosclerosis from the Hybrid Mouse Diversity Panel (HMDP) followed by integration with functional multiomics human (STARNET and GTEx) and mouse (HMDP) databases. We found that mouse and human shared >75% of CAD causal pathways. Based on network topology, we then predicted key regulatory genes for both the shared pathways and species-specific pathways, which were further validated through the use of single cell data and the latest CAD GWAS. In sum, our results should serve as a much-needed guidance for which human CAD-causal pathways can or cannot be further evaluated for novel CAD therapies using mouse models.
- Published
- 2023